Molecular genetic studies using whole-exome sequencing have shown that mutations carriers of both the HMBS gene and the ALAD gene may not necessarily affect AIP clinical manifestation, and mutations in genes regulating nervous system genes contributed to AIP manifestation [25]. The gene discussed is ALAD; the disease is autoimmune pancreatitis.